Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $119000.0.

  • Palisade Bio's Other Non-Current Assets fell 6327.16% to $119000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $119000.0, marking a year-over-year decrease of 6327.16%. This contributed to the annual value of $273000.0 for FY2024, which is 4428.57% down from last year.
  • According to the latest figures from Q3 2025, Palisade Bio's Other Non-Current Assets is $119000.0, which was down 6327.16% from $171000.0 recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's Other Non-Current Assets registered a high of $860702.0 during Q1 2021, and its lowest value of $26000.0 during Q2 2021.
  • In the last 5 years, Palisade Bio's Other Non-Current Assets had a median value of $355500.0 in 2024 and averaged $366927.9.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first crashed by 9710.96% in 2021, then skyrocketed by 276923.08% in 2022.
  • Palisade Bio's Other Non-Current Assets (Quarter) stood at $26000.0 in 2021, then soared by 2569.23% to $694000.0 in 2022, then dropped by 29.39% to $490000.0 in 2023, then crashed by 44.29% to $273000.0 in 2024, then plummeted by 56.41% to $119000.0 in 2025.
  • Its Other Non-Current Assets was $119000.0 in Q3 2025, compared to $171000.0 in Q2 2025 and $222000.0 in Q1 2025.